UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000036417 |
|---|---|
| Receipt number | R000041491 |
| Scientific Title | Renal protective effect of tolvaptan in patients with new-onset acute heart failure |
| Date of disclosure of the study information | 2019/05/15 |
| Last modified on | 2022/06/19 12:14:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/04/05 13:02:28 | ||
| 2 | Update | 2019/04/27 19:22:10 | Narrative objectives1 Narrative objectives1 Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2019/04/27 19:23:56 | Key inclusion criteria |
|
| 4 | Update | 2019/04/27 19:24:51 | Date of disclosure of the study information |
|
| 5 | Update | 2019/04/27 19:26:57 | Anticipated trial start date Other related information Other related information |
|
| 6 | Update | 2019/04/27 19:28:17 | Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2019/05/15 17:34:44 | Public title Scientific Title |
|
| 8 | Update | 2019/05/15 17:36:55 | Date of disclosure of the study information |
|
| 9 | Update | 2019/05/15 17:39:00 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 10 | Update | 2019/05/18 11:31:39 | Recruitment status |
|
| 11 | Update | 2019/05/18 12:15:07 | Key secondary outcomes Key secondary outcomes |
|
| 12 | Update | 2020/01/28 08:25:19 | Recruitment status |
|
| 13 | Update | 2020/04/04 12:52:47 | Publication of results Number of participants that the trial has enrolled |
|
| 14 | Update | 2020/10/05 09:20:52 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 15 | Update | 2022/06/19 12:14:17 | Recruitment status |
